Fareon Open Label Device Clinical Trial
NCT: NCT07600320 · NOT_YET_RECRUITING
Brief Summary
The purpose of this study is to assess the safety and feasibility of an at-home MMT treatment in patients with cognitive dysfunction related to acquired brain injury, Long COVID, traumatic brain injury, myalgic encephalomyelitis (ME/CFS), and other neurodegenerative diagnoses including but not limited to Alzheimer's disease and to collect data on safety and efficacy to inform the design of larger clinical studies.
Frequently Asked Questions
What is Fareon Open Label Device Clinical Trial?
Fareon Open Label Device Clinical Trial is a clinical trial registered under NCT07600320. Current status: NOT_YET_RECRUITING.
What is the status of NCT07600320?
The current status of NCT07600320 (Fareon Open Label Device Clinical Trial) is: NOT_YET_RECRUITING.
When did Fareon Open Label Device Clinical Trial start?
Fareon Open Label Device Clinical Trial started on 2026-05-01.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.